School of Medicine
Showing 31-40 of 126 Results
-
Rory Hills
Postdoctoral Scholar, Pathology
BioI work at the intersection of protein engineering, immunology, and translational medicine. My research focuses on building generalizable molecular tools to better measure and manipulate complex human disease. At Stanford, I am developing modular antibody platforms that enable high-resolution, spatial analysis of cancer and immune systems in intact tissue. I previously trained at Oxford and Cambridge, where I worked on next-generation vaccine platforms with collaborators across academia and industry.
-
Rongting Huang
Postdoctoral Scholar, Pathology
BioDr. Huang is a computational biologist with academic interests in cancer genomics and spatial biology, particularly in the field of gynecologic cancers. During her Ph.D. under the mentorship of Dr. Yuanhua Huang, she developed statistical methods to detect allele-specific somatic copy number variations from single-cell and spatial transcriptomic data, aiming to understand genetic diversity in biological systems. Currently, her research focuses on advancing gynecologic cancer studies and women’s health through spatial technology platforms, computational modeling, and innovative data visualizations to uncover meaningful insights.
Outside of research, she enjoys hiking, rock climbing, and calligraphy, which help her stay creative and balanced. -
Iman Jaljuli
Postdoctoral Scholar, Pathology
BioPhD in Statistics,
Tel-Aviv University -
Rathinaraja Jeyaraj
Postdoctoral Scholar, Pathology
BioMy research interests revolve around unboxing, manipulating, and applying machine and deep learning algorithms to address computer vision challenges. Currently, I focus on histopathology image analytics using contrastive learning and multi-modal representation learning (image and text).
-
Jeyun Jo
Postdoctoral Scholar, Pathology
BioDr. Jeyun Jo received his Pharm.D. from Pusan National University in 2016 and his Ph.D. in pharmacy at the same institution in 2021. His thesis studies focused on the first total synthesis of anmindenol A and optimization of 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cells. He then worked for one year as a senior research scientist at Chong Kun Dang, a leading pharmaceutical company in Korea, where he developed large-sacale synthetic processes for engineered peptides. In May 2022, he joined the Bogyo lab at Stanford University as a postdoctoral fellow. His current research focuses on developing highly selective inhibitors and activity-based probes targeting specific serine hydrolases in pathogenic bacteria and cancer.
